Child-friendly formulation of WHO-recommended treatment now approved by the US FDA for children living with HIV

[Geneva, Switzerland – 3 June 2015]
The Paediatric HIV Treatment Initiative* welcomes this important step towards closing the treatment gap for children with HIV

Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration’s (FDA) tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla.

CNet Japan [19 May, 2015]
“国境なき医師団(MSF)とDNDiは、緊急の国際医療ニーズに向け生物医学研究開発(R&D)基金ならびに機構の設立を働きかけています”  MSF and DNDi Join Call for a Biomedical Research and Development Fund and Mechanism to Meet Pressing Global Health Needs”
Click here to read the article